Stocks
Affimed (AFMD) R&D US GAAP (year values) |
|||||||||
| FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | LTM ? | CAGR 5 years ? | |||
| R&D, € | 43 791 000 | 49 989 000 | 81 488 000 | 98 814 000 | 94 958 000 | 55 910 000 | |||
| Changes by years, y/y, % | +25% | +14% | +63% | +21% | -4% | +22.0% | |||
Affimed. R&D, €
Affimed. R&D, changes, %
Affimed. R&D, sum by quarters, €
Affimed (AFMD) R&D US GAAP (quarter values) |
||||||||
| FY2023Q3 | FY2023Q4 | FY2024Q1 | FY2024Q2 | FY2024Q3 | LTM ? | |||
| R&D, € | 21 498 000 | 18 656 000 | 15 391 000 | 11 727 000 | 10 136 000 | 55 910 000 | ||
| Changes by years, y/y, % | -18% | -44% | -48% | -54% | -53% | |||
| Changes by quarters, q/q, % | -15% | -13% | -18% | -24% | -14% | |||
